Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric <i>Fok</i>I Nuclease Domains

Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric <i>Fok</i>I Nuclease Domains

Persistent hepatitis B virus (HBV) infection remains a serious medical problem worldwide, with an estimated global burden of 257 million carriers. Prophylactic and therapeutic interventions, in the form of a vaccine, immunomodulators, and nucleotide and nucleoside analogs, are available. Vaccination...

Full description

Bibliographic Details
Main Authors:	Tiffany Smith, Prashika Singh, Kay Ole Chmielewski, Kristie Bloom, Toni Cathomen, Patrick Arbuthnot, Abdullah Ely
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Viruses
Subjects:	HBV cccDNA obligate heterodimeric TALENs Sharkey
Online Access:	https://www.mdpi.com/1999-4915/13/7/1344

Similar Items

Heterodimeric TALENs induce targeted heritable mutations in the crustacean Daphnia magna
by: Akiko Naitou, et al.
Published: (2015-02-01)

Gene Editing Technologies to Target HBV cccDNA
by: Maria Guadalupe Martinez, et al.
Published: (2022-11-01)

T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds
by: Manuel Rhiel, et al.
Published: (2023-02-01)

Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional CureSummary
by: Takashi Honda, et al.
Published: (2021-01-01)

Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
by: Fiona van den Berg, et al.
Published: (2020-08-01)

Evaluation of the HBV liver reservoir with fine needle aspirates
by: Barbara Testoni, et al.
Published: (2023-10-01)

cccDNA Surrogate MC-HBV–Based Screen Identifies Cohesin Complex as a Novel HBV Restriction FactorSummary
by: Zhuanchang Wu, et al.
Published: (2022-01-01)

Detection of HBV Covalently Closed Circular DNA
by: Xiaoling Li, et al.
Published: (2017-06-01)

Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA
by: An-Qi Zhuang, et al.
Published: (2023-11-01)

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease
by: Andrea Magri, et al.
Published: (2022-05-01)

CRISPR/Cas9 for hepatitis B virus infection treatment
by: Bo Cai, et al.
Published: (2023-05-01)

Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design
by: Sumitra Shankar, et al.
Published: (2018-10-01)

Immunoinformatics and Evaluation of Peptide Vaccines Derived from Global Hepatitis B Viral HBx and HBc Proteins Critical for Covalently Closed Circular DNA Integrity
by: Umar Saeed, et al.
Published: (2023-11-01)

Differences in sequences between HBV-relaxed circular DNA and covalently closed circular DNA
by: Magda Rybicka, et al.
Published: (2017-01-01)

Role of epigenetic modification in interferon treatment of hepatitis B virus infection
by: Zhijing Yang, et al.
Published: (2022-10-01)

Hepatitis B Virus Utilizes a Retrograde Trafficking Route via the Trans-Golgi Network to Avoid Lysosomal DegradationSummary
by: Ying-Yi Li, et al.
Published: (2023-01-01)

When Hepatitis B Virus Meets Interferons
by: Guangyun Tan, et al.
Published: (2018-07-01)

Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
by: Yi Yang, et al.
Published: (2018-01-01)

Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation
by: Jun Luo, et al.
Published: (2020-02-01)

Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators
by: Sandesha Nayak, et al.
Published: (2023-11-01)

ZNF148 inhibits HBV replication by downregulating RXRα transcription
by: Xinyan Yao, et al.
Published: (2024-01-01)

Potential antiviral activities of chrysin against hepatitis B virus
by: Sajad Ahmad Bhat, et al.
Published: (2023-03-01)

Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen
by: Bingqian Qu, et al.
Published: (2022-10-01)

The epigenetic control of hepatitis B virus modulates the outcome of infection
by: Lemonica eKoumbi, et al.
Published: (2016-01-01)

Post-translational Modification Control of HBV Biological Processes
by: Fan Yang
Published: (2018-11-01)

Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production
by: Julie Lucifora, et al.
Published: (2021-10-01)

Dynamics of HBV cccDNA expression and transcription in different cell growth phase
by: Chong Chin-Liew, et al.
Published: (2011-12-01)

Identifying and Characterizing Interplay between Hepatitis B Virus X Protein and Smc5/6
by: Christine M. Livingston, et al.
Published: (2017-04-01)

Improving prediction of heterodimeric protein complexes using combination with pairwise kernel
by: Peiying Ruan, et al.
Published: (2018-02-01)

Hepatitis B Virus Capsid: The Core in Productive Entry and Covalently Closed Circular DNA Formation
by: Megan A. Mendenhall, et al.
Published: (2023-02-01)

Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy
by: Eriko Ohsaki, et al.
Published: (2021-08-01)

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
by: François Villeret, et al.
Published: (2023-06-01)

Establishment of a fluorescent in situ hybridization assay for imaging hepatitis B virus nucleic acids in cell culture models
by: Xiaonan Zhang, et al.
Published: (2017-01-01)

SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters
by: Dai-Qing Wu, et al.
Published: (2022-05-01)

A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome
by: Robert L. Kruse, et al.
Published: (2021-04-01)

Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future
by: Xiaonan Zhang, et al.
Published: (2021-07-01)

A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNASummary
by: Zaichao Xu, et al.
Published: (2022-01-01)

Creation of targeted genomic deletions using TALEN or CRISPR/Cas nuclease pairs in one‐cell mouse embryos
by: Christina Brandl, et al.
Published: (2015-01-01)

Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
by: Rishi K. Somvanshi, et al.
Published: (2012-04-01)

cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels
by: Ee Chee Ren, et al.
Published: (2023-09-01)